AI-designed drug shows early promise for lung fibrosis patients in clinical trial

A groundbreaking phase 2a study reveals that rentosertib, an AI-developed TNIK inhibitor, could offer new hope…

Ron Perelman’s Fight Over $410 Million in Art Insurance Goes to Trial

Nearly seven years after a fire ripped through Ron Perelman’s Hamptons home, he is asking a…

EY Negligently Missed Huge Fraud at Collapsed Hospital Operator, $3B UK Trial Hears

EY failed to spot a major fraud by main shareholders of UAE hospital operator NMC Health…